Vinorelbine/carboplatin vs gemcitabine/carboplatin in advanced NSCLC shows similar efficacy, but different impact of toxicity

This randomised phase III study in advanced non-small cell lung cancer (NSCLC) patients was conducted to compare vinorelbine/carboplatin (VC) and gemcitabine/carboplatin (GC) regarding efficacy, health-related quality of life (HRQOL) and toxicity. Chemonaive patients with NSCLC stage IIIB/IV and WHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Helbekkmo, N, Sundstrøm, S H, Aasebø, U, Fr Brunsvig, P, von Plessen, C, Hjelde, H H, Garpestad, O K, Bailey, A, Bremnes, R M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360329/
https://www.ncbi.nlm.nih.gov/pubmed/17595658
http://dx.doi.org/10.1038/sj.bjc.6603869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360329/
https://www.ncbi.nlm.nih.gov/pubmed/17595658
http://dx.doi.org/10.1038/sj.bjc.6603869

Ejemplares similares